These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 36593954)

  • 1. Artificial intelligence-based recognition for variant pathogenicity of BRCA1 using AlphaFold2-predicted structures.
    Li C; Zhang L; Zhuo Z; Su F; Li H; Xu S; Liu Y; Zhang Z; Xie Y; Yu X; Bian L; Xiao F
    Theranostics; 2023; 13(1):391-402. PubMed ID: 36593954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting the pathogenicity of missense variants using features derived from AlphaFold2.
    Schmidt A; Röner S; Mai K; Klinkhammer H; Kircher M; Ludwig KU
    Bioinformatics; 2023 May; 39(5):. PubMed ID: 37084271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic misclassification of missense variants in BRCA1 and BRCA2 "coldspots".
    Dines JN; Shirts BH; Slavin TP; Walsh T; King MC; Fowler DM; Pritchard CC
    Genet Med; 2020 May; 22(5):825-830. PubMed ID: 31911673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural and functional prediction, evaluation, and validation in the post-sequencing era.
    Li C; Luo Y; Xie Y; Zhang Z; Liu Y; Zou L; Xiao F
    Comput Struct Biotechnol J; 2024 Dec; 23():446-451. PubMed ID: 38223342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation and Data-Integration of Yeast-Based Assays for Functional Classification of BRCA1 Missense Variants.
    Bellè F; Mercatanti A; Lodovichi S; Congregati C; Guglielmi C; Tancredi M; Caligo MA; Cervelli T; Galli A
    Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional Categorization of
    Bouwman P; van der Heijden I; van der Gulden H; de Bruijn R; Braspenning ME; Moghadasi S; Wessels LFA; ; Vreeswijk MPG; Jonkers J
    Clin Cancer Res; 2020 Sep; 26(17):4559-4568. PubMed ID: 32546644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The BRCA1 variant p.Ser36Tyr abrogates BRCA1 protein function and potentially confers a moderate risk of breast cancer.
    Christou CM; Hadjisavvas A; Kyratzi M; Flouri C; Neophytou I; Anastasiadou V; Loizidou MA; Kyriacou K
    PLoS One; 2014; 9(4):e93400. PubMed ID: 24695549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integration of functional assay data results provides strong evidence for classification of hundreds of BRCA1 variants of uncertain significance.
    Lyra PCM; Nepomuceno TC; de Souza MLM; Machado GF; Veloso MF; Henriques TB; Dos Santos DZ; Ribeiro IG; Ribeiro RS; Rangel LBA; Richardson M; Iversen ES; Goldgar D; Couch FJ; Carvalho MA; Monteiro ANA
    Genet Med; 2021 Feb; 23(2):306-315. PubMed ID: 33087888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Collective evidence supports neutrality of BRCA1 V1687I, a novel sequence variant in the conserved THV motif of the first BRCT repeat.
    Cortesi L; De Nicolo A; Medici V; Marino M; Turchetti D; Pradella LM; Rossi G; Parisini E; Federico M
    Breast Cancer Res Treat; 2012 Jul; 134(1):435-41. PubMed ID: 22527099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reinterpretation of BRCA1 and BRCA2 variants of uncertain significance in patients with hereditary breast/ovarian cancer using the ACMG/AMP 2015 guidelines.
    So MK; Jeong TD; Lim W; Moon BI; Paik NS; Kim SC; Huh J
    Breast Cancer; 2019 Jul; 26(4):510-519. PubMed ID: 30725392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combining Homologous Recombination and Phosphopeptide-binding Data to Predict the Impact of
    Petitalot A; Dardillac E; Jacquet E; Nhiri N; Guirouilh-Barbat J; Julien P; Bouazzaoui I; Bonte D; Feunteun J; Schnell JA; Lafitte P; Aude JC; Noguès C; Rouleau E; Lidereau R; Lopez BS; Zinn-Justin S; Caputo SM;
    Mol Cancer Res; 2019 Jan; 17(1):54-69. PubMed ID: 30257991
    [No Abstract]   [Full Text] [Related]  

  • 12. Understanding and predicting the functional consequences of missense mutations in BRCA1 and BRCA2.
    Aljarf R; Shen M; Pires DEV; Ascher DB
    Sci Rep; 2022 Jun; 12(1):10458. PubMed ID: 35729312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trans-activation-based risk assessment of BRCA1 BRCT variants with unknown clinical significance.
    Langerud J; Jarhelle E; Van Ghelue M; Ariansen SL; Iversen N
    Hum Genomics; 2018 Nov; 12(1):51. PubMed ID: 30458859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BRCA1/2 sequence variants of uncertain significance: a primer for providers to assist in discussions and in medical management.
    Lindor NM; Goldgar DE; Tavtigian SV; Plon SE; Couch FJ
    Oncologist; 2013; 18(5):518-24. PubMed ID: 23615697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AI-derived comparative assessment of the performance of pathogenicity prediction tools on missense variants of breast cancer genes.
    Ahmad RM; Ali BR; Al-Jasmi F; Al Dhaheri N; Al Turki S; Kizhakkedath P; Mohamad MS
    Hum Genomics; 2024 Sep; 18(1):99. PubMed ID: 39256852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic, functional, and histopathological evaluation of two C-terminal BRCA1 missense variants.
    Lovelock PK; Healey S; Au W; Sum EY; Tesoriero A; Wong EM; Hinson S; Brinkworth R; Bekessy A; Diez O; Izatt L; Solomon E; Jenkins M; Renard H; Hopper J; Waring P; Tavtigian SV; Goldgar D; Lindeman GJ; Visvader JE; Couch FJ; Henderson BR; Southey M; Chenevix-Trench G; Spurdle AB; Brown MA;
    J Med Genet; 2006 Jan; 43(1):74-83. PubMed ID: 15923272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Missense variants of uncertain significance (VUS) altering the phosphorylation patterns of BRCA1 and BRCA2.
    Tram E; Savas S; Ozcelik H
    PLoS One; 2013; 8(5):e62468. PubMed ID: 23704879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional impact of missense variants in BRCA1 predicted by supervised learning.
    Karchin R; Monteiro AN; Tavtigian SV; Carvalho MA; Sali A
    PLoS Comput Biol; 2007 Feb; 3(2):e26. PubMed ID: 17305420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reclassification of
    Ha HI; Ryu JS; Shim H; Kong SY; Lim MC
    J Gynecol Oncol; 2020 Nov; 31(6):e83. PubMed ID: 33078592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using AI-predicted protein structures as a reference to predict loss-of-function activity in tumor suppressor breast cancer genes.
    Gnanaolivu R; Hart SN
    Comput Struct Biotechnol J; 2024 Dec; 23():3472-3480. PubMed ID: 39430403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.